Do You Have the COVID Protection You Need as You Wait For A Booster? A New Test From Epitome Risk Lets You Know

News provided by

Epitome Risk

Sep 28, 2021, 09:33 ET

FLAGLER BEACH, Fla., Sept. 28, 2021 /PRNewswire/ -- Neutralizing antibodies recognize the coronavirus and block it. Your body makes the COVID-blocking neutralizing antibodies after you get your Pfizer, Moderna or Johnson & Johnson vaccine or had COVID, says Lisa Wilson, CEO of Epitome Risk.

Continue Reading
Epitome is a U.S. based risk management company, specializing in COVID-19 compliance & safety support. We are the leading provider of Neutralizing Antibody tests.
Epitome is a U.S. based risk management company, specializing in COVID-19 compliance & safety support. We are the leading provider of Neutralizing Antibody tests.
Millet worked with Epitome Risk CEO Lisa Wilson to develop a new protocol for cPass ™. cPass ™, the new test protocol offered by Epitome Risk, is helping people understand how well their SARS-CoV-2 vaccine is working. Unlike other tests the Center For Disease Control (CDC) warns against, cPass ™developed by Genscript and sold by Epitome Risk, zeros in on the exact subsect of antibodies that block the virus from attacking your cells. cPass ™has been awarded the Federal Drug Administration (FDA (PRNewsfoto/Epitome Risk)
Millet worked with Epitome Risk CEO Lisa Wilson to develop a new protocol for cPass ™. cPass ™, the new test protocol offered by Epitome Risk, is helping people understand how well their SARS-CoV-2 vaccine is working. Unlike other tests the Center For Disease Control (CDC) warns against, cPass ™developed by Genscript and sold by Epitome Risk, zeros in on the exact subsect of antibodies that block the virus from attacking your cells. cPass ™has been awarded the Federal Drug Administration (FDA (PRNewsfoto/Epitome Risk)

"With COVID and its variants, people want to manage their own health and wellness," said Wilson. "Because the neutralizing antibody test is ordered directly by consumers online it is usually not covered by health insurance. Employees with a flexible spending account (FSA) or a health reimbursement arrangement (HRA) can use that money to pay for the test."

Vaccine makers announced that the number of COVID-blocking neutralizing antibodies goes down about six months after you got the vaccine. The White House is not offering booster shots to the general public yet. How do you know if your vaccine is still protecting you from COVID?

Epitome Risk is the only company offering a neutralizing antibody test from the comfort of your own home. Now you can order the only at-home neutralizing antibody test from Fourthwall Testing, owned by Epitome Risk.

"In 24-48 hours, you'll know if your immune system is protecting you from COVID after you got your Johnson & Johnson, Moderna, or Pfizer vaccine, or after you tested positive for COVID, Wilson said.

The Testing Process

Step 1
Order your neutralizing antibody test kit: The test kit materials will be delivered right to your doorstep and includes pre-paid expedited shipping to send your sample to the lab.

Step 2
Collect your sample: Collect your sample and drop it in the mail. Within 24-48 hours your sample will be tested and analyzed using the first-in-the-world at-home neutralizing antibody test with the capability of measuring neutralizing antibodies.

Step 3
Receive results in days: Results, analysis and explanations will be available by email. If you have any questions, call our live help line. We are here to help.

Step 4
Share your results. Easily share your results with your doctor, employer or family members. We're all interconnected and are fighting COVID together.

About Epitome Risk
Epitome is a U.S.-based risk management company, specializing in COVID-compliance & safety support for tv & film productions. Through working with industry-leading international partners, Epitome delivers the highest level of logistical and risk analysis and consulting for the unique needs of on-location television and film production.

Media Contact:
Karen Campbell
[email protected]  
667-206-0208
*Lisa Wilson is available for interviews

SOURCE Epitome Risk

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED